AbbVie Demonstrates Leadership in HCV with New MAVYRET™ (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017

Media coverage

• Title	AbbVie Demonstrates Leadership in HCV with New MAVYRET™ (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
  Media name/outlet	TickerTech.com
  Country	United States
  Date	10/11/17
  Persons	Fred Poordad

• Title	ABBVIE : Demonstrates Leadership in HCV with New MAVYRET™ (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
  Media name/outlet	4 Traders
  Country	United States
  Date	10/11/17
  Persons	Fred Poordad